Esperion Therapeutics, Inc.

NasdaqGM:ESPR Stock Report

Market Cap: US$448.9m

Esperion Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:ESPR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Sep 23SellUS$924Eric WarrenIndividual742US$1.25
18 Aug 23SellUS$344Eric WarrenIndividual243US$1.41
19 Jul 23SellUS$168Eric WarrenIndividual106US$1.59
21 Jun 23SellUS$894Eric WarrenIndividual603US$1.48
17 May 23SellUS$356Eric WarrenIndividual219US$1.62
11 May 23BuyUS$48,831J. CarrollIndividual31,500US$1.57
10 May 23BuyUS$12,126Stephen RocamboliIndividual8,111US$1.50
09 May 23BuyUS$25,192Sheldon KoenigIndividual20,000US$1.26

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ESPR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies9,6000.00507%
Individual Insiders900,2970.475%
Institutions74,027,79439.1%
General Public114,462,87660.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 112.6%.


Top Shareholders

Top 25 shareholders own 33.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.85%
Bellevue Asset Management AG
9,194,064US$21.8m119%0.21%
4.82%
Wasatch Advisors LP
9,129,647US$21.6m2.68%0.07%
4.06%
Two Seas Capital LP
7,686,120US$18.2m0.18%3.79%
2.71%
The Vanguard Group, Inc.
5,137,750US$12.2m8.36%no data
2%
Meditor Group Ltd.
3,791,300US$9.0m0%4.05%
1.82%
Millennium Management LLC
3,449,451US$8.2m-40.5%0.01%
1.48%
Platinum Investment Management Limited
2,810,555US$6.7m-11.9%0.17%
1.23%
Two Sigma Investments, LP
2,334,410US$5.5m60.1%0.01%
1.13%
Two Sigma Advisers, LP
2,146,600US$5.1m39.7%0.01%
1.12%
BlackRock, Inc.
2,112,899US$5.0m7.37%no data
0.98%
Tang Capital Management, LLC
1,850,000US$4.4m0%0.39%
0.8%
Susquehanna International Group, LLP, Asset Management Arm
1,506,520US$3.6m152%no data
0.78%
JP Morgan Asset Management
1,479,609US$3.5m0.85%no data
0.75%
Parkman Healthcare Partners LLC
1,425,204US$3.4m-28.6%0.38%
0.75%
Renaissance Technologies LLC
1,420,100US$3.4m589%no data
0.64%
D. E. Shaw & Co., L.P.
1,213,203US$2.9m0%no data
0.59%
Geode Capital Management, LLC
1,112,246US$2.6m14.6%no data
0.58%
Schonfeld Strategic Advisors LLC
1,091,328US$2.6m-11.4%0.02%
0.56%
Jacobs Levy Equity Management Inc
1,057,884US$2.5m-53.3%0.01%
0.56%
Goldman Sachs Group, Investment Banking and Securities Investments
1,057,401US$2.5m-9.06%no data
0.49%
Morgan Stanley, Investment Banking and Brokerage Investments
921,323US$2.2m-51.9%no data
0.47%
Whitefort Capital Management, LP
885,522US$2.1m0%1.07%
0.28%
UBS O'Connor LLC
527,123US$1.2m-16.6%0.09%
0.25%
Parallel Advisors, LLC
478,000US$1.1m0%0.03%
0.24%
Citadel Advisors LLC
462,282US$1.1m-29.1%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.